Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

In-Process Control: SOP for Ensuring Accuracy of In-Process Weight Checks – V 2.0

Posted on By

In-Process Control: SOP for Ensuring Accuracy of In-Process Weight Checks – V 2.0

Standard Operating Procedure for Ensuring Accuracy of In-Process Weight Checks


Department In-Process Control
SOP No. SOP/IPC/171/2025
Supersedes SOP/IPC/171/2022
Page No. Page 1 of 14
Issue Date 25/06/2025
Effective Date 27/06/2025
Review Date 25/06/2026

1. Purpose

The purpose of this SOP is to define a systematic procedure to ensure the accuracy of in-process weight checks during the manufacturing of sterile injectable products. It helps to maintain compliance with GMP regulations and ensure consistency and quality of the final

product.

2. Scope

This SOP applies to all manufacturing processes involving filling, sealing, and labeling of injectable products in vials, ampoules, and prefilled syringes where weight verification is part of in-process control (IPC) at the sterile manufacturing facility.

3. Responsibilities

  • Manufacturing Operator: To perform weight checks as per the batch record and SOP.
  • IPQA Officer: To verify, record, and ensure compliance of weight check limits and frequency.
  • QA Executive: To review the weight check documentation and initiate necessary deviation reports for any non-conformity.

4. Accountability

The Head of Quality Assurance is accountable for implementation and compliance with this SOP across sterile manufacturing areas.

See also  Manufacturing: SOP for Documentation of In-Process Observations - V 2.0

5. Procedure

5.1 Preparation for Weight Checks

  1. Ensure the balance or check weigher is calibrated and verified before use. Refer to the Balance Calibration Log (Annexure-1).
  2. Use only identified and labeled balances for IPC weight checks.
  3. Verify the equipment ID and location before initiating weight checks.

5.2 Execution of Weight Checks

  1. Collect a predefined number of units (e.g., 10 vials) from the filling line every 30 minutes or as per the BMR.
  2. Place each unit individually on the balance and record the gross weight.
  3. Refer to the Tare weight of the container (vial, ampoule, or syringe) as per specification.
  4. Calculate the net fill weight: Gross weight – Tare weight = Net weight.
  5. Compare the net weight against the approved specification/range stated in the product specification sheet.
  6. Record all weights in the Weight Verification Log (Annexure-2).

5.3 Acceptance Criteria

  • Net weight must fall within ±5% of labeled fill weight unless otherwise specified.
  • If any unit is found out of specification, perform a second check with another set of 10 units.
  • If failure is confirmed, immediately inform Production and QA. Initiate deviation and investigate root cause.

5.4 Frequency of Checks

  • Initial check: Before batch filling starts (trial run verification).
  • Routine checks: At predefined intervals during filling.
  • Post-run check: After filling operation is completed.
  • Additional checks: If any abnormality or deviation is observed in the line or weight trends.
See also  Sterile Injectable Manufacturing: SOP for Documentation of In-Process Control Activities - V 2.0

5.5 Handling Out-of-Limit Results

  1. Segregate the affected batch quantity filled since the last satisfactory check.
  2. Review line parameters (nozzle clogging, vacuum sealing, equipment speed, air pressure, etc.).
  3. Document all observations and findings in Deviation Report Form (Annexure-3).
  4. Rectify the root cause before restarting filling operation.

5.6 Documentation Requirements

  1. Fill all records with blue ink. Do not leave blanks. Use ‘NA’ if not applicable.
  2. Ensure all entries are reviewed and signed by IPQA before continuation of filling.
  3. Attach the weight check data with the respective batch manufacturing records.
  4. Maintain trend data for weight checks for all products for ongoing process monitoring.

5.7 Training

  1. All personnel involved in IPC weight checks must be trained in the use of balances and GMP practices.
  2. Training must be documented in the Training Record Log (Annexure-4).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPC: In-Process Control
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • IPQA: In-Process Quality Assurance

7. Documents

  1. Balance Calibration Log – Annexure-1
  2. Weight Verification Log – Annexure-2
  3. Deviation Report Form – Annexure-3
  4. Training Record Log – Annexure-4
See also  Sterile Injectable Manufacturing: SOP for Preparing Master Formula for Injectable Products - V 2.0

8. References

  • WHO GMP Guidelines for Sterile Products
  • 21 CFR Part 211 – Current Good Manufacturing Practice
  • ICH Q8(R2) – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Production Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Balance Calibration Log

Balance ID Location Last Calibration Next Due Status
BLN-01 Filling Room 01/06/2025 01/12/2025 Calibrated

Annexure-2: Weight Verification Log

Date Batch No. Time Unit No. Gross Weight (mg) Net Weight (mg) Result Checked By
24/06/2025 INJ/0625/01 10:00 1 515 500 Pass Rajesh Kumar

Annexure-3: Deviation Report Form

Deviation ID Date Description Immediate Action Corrective/Preventive Action Approved By
DEV/IPC/005 24/06/2025 Weight below limit in 2 units Line paused Nozzle cleaned, line retrained Sunita Reddy

Annexure-4: Training Record Log

Employee Name Department Training Date Trainer Remarks
Ajay Mehta Production 15/06/2025 QA Executive Completed

Revision History:

Revision Date Revision No. Details Reason Approved By
01/07/2022 1.0 Initial version New SOP Head QA
25/06/2025 2.0 Updated procedure steps and annexures Annual Review Head QA
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Selecting Bio-Adhesive Polymers for Gels – V 2.0
Next Post: Temporary SOP Changes Without Change Control: A Hidden Compliance Gap

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version